SUNNYVALE, Calif., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY - News), a global leader in the field of radiosurgery, announced today the results of an independent survey that confirms that the CyberKnife® Robotic Radiosurgery System dominates the field of extracranial
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems SUNNYVALE, Calif. , Aug. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the Summit Cancer
Fifth Users' Meeting Highlights Efficacy of TomoTherapy® Treatment System and Widespread Acceptance Across the Region SUNNYVALE, Calif. , Oct. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its TomoTherapy ®
CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery SUNNYVALE, Calif. , Jan. 29, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a study of 138 patients
Data provides new support for efficacy and toxicity benefits of non-invasively delivering High Dose Rate Brachytherapy dosing to patients with prostate cancer SUNNYVALE, Calif. , Jan. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today
CyberKnife System Broadens Range of Lung Cancer Patients Treatable with SBRT SUNNYVALE, Calif. , Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic
SUNNYVALE, Calif. , Feb. 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy ® System in the treatment of advanced rectal cancer. Radiotherapy, with or without chemotherapy, followed by surgery is the
Additional Data Demonstrate Accuray TomoTherapy and CyberKnife® Systems Provide Precise Dose Delivery and Tumor Management SUNNYVALE, Calif. , Sept. 18, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 56th Annual American Society for Radiation
New System will be Used to Treat Diseases in the Brain and Base of the Skull SUNNYVALE, Calif. , Dec. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Stanford University Medical Center has selected a second CyberKnife ® M6™ System to expand access to precise
Prior Studies Demonstrate Frequency of Prostate Motion, Supporting Need for the CyberKnife System's Real-Time Tracking to Spare Surrounding Sensitive Structures SUNNYVALE, Calif ., March 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.